TKTodd Matthew Kolb

Todd Matthew Kolb

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Todd Matthew Kolb has a total of 231 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Multicellular Programs Associated with Right Ventricular Adaptation in Pulmonary Arterial Hypertension

    by Catherine E. Simpson, Darin T. Rosen, Andrea Bredemeyer, Haewon Shin, Julie C. Coursen, Sarah L. Khan, Aparna Balasubramanian, Todd M. Kolb, Stephen C. Mathai, Rachel L. Damico, et al.

    Background: Right ventricular (RV) adaptation determines outcomes in pulmonary arterial hypertension (PAH), yet multicellular molecular programs associated with adaptive versus maladaptive RV remodeling in living humans remain incompletely defined. Methods: We collected 32 human RV tissue biopsies from patients with idiopathic PAH, systemic sclerosis-associated PAH (SSc-PAH), systemic sclerosis without pulmonary hypertension, with 24 nonfailing donor RVs serving as controls. We performed single-nucleus RNA sequencing and integrated cell-type specific transcriptional programs with contemporaneously obtained multi-beat pressure-volume loop measurements of RV contractility (Ees, end-systolic elastance) and RV-pulmonary arterial coupling (the ratio of Ees to Ea, the effective arterial load). SSc modification of PAH-associated biology was assessed using interaction terms. Bulk RV proteomic pathway enrichment was performed to assess an orthogonal molecular layer, and exploratory cell-cell communication analyses alongside independent spatial transcriptomic analyses were performed to contextualize key findings. Results: PAH was associated with broad depletion of biosynthetic, trafficking, and mitochondrial programs across cell types. SSc modified the magnitude of many PAH-associated transcriptional programs while largely preserving pathway directionality. Significant multicellular pathway enrichments were associated with RV-pulmonary arterial coupling. Joint analysis of Ees, Ea, and Ees/Ea identified biologic programs associated with different RV responses to varying loading conditions. Preserved coupling was characterized by enriched extracellular matrix, laminin-integrin, receptor tyrosine kinase, mitochondrial, and translational programs involving fibroblast, endothelial, endocardial, and cardiomyocyte compartments. Cell- cell communication analyses predicted coordinated stromal-vascular signaling networks involving laminin-integrin and endothelial-to-mural signaling in preserved coupling. Proteomic and spatial analyses supported recurrent multicellular themes. Conclusions: RV adaptation in PAH is associated with distinct, coordinated multicellular programs that vary with load and contractile response. RV-PA coupling in PAH is associated with multicellular remodeling that extends beyond cardiomyocytes and reflects organized vascular-stromal support architecture. These findings identify extracellular matrix, laminin- integrin signaling, mitochondrial, and translational programs as associated with adaptive RV remodeling in PAH. Clinical Perspective: What is new?: Cell type-resolved molecular profiling of living human RV tissue identifies PAH-associated depletion of biosynthetic, trafficking, mitochondrial, and repair-associated programs across multiple cardiac cell types. Integration with contemporaneously obtained pressure-volume loop physiology demonstrates that preserved RV-pulmonary arterial coupling under lower load was associated predominantly with cardiomyocyte mitochondrial and metabolic competency, whereas preserved coupling under higher load was associated with extracellular matrix remodeling and vascular-stromal signaling. Proteomic, cell-cell communication, and spatial analyses provided orthogonal support for coordinated extracellular matrix and vascular-stromal programs associated with preserved RV-pulmonary arterial coupling. What are the clinical implications?: These findings shift the biology of RV adaptation from a predominantly cardiomyocyte- centered model toward a multicellular tissue model in which metabolic, matrix, and vascular support programs vary according to loading conditions and contractile states. Extracellular matrix-integrin signaling, endothelial-mural communication, and mitochondrial competency represent candidate pathways for mechanistic investigation toward RV-directed therapies in PAH.

  • Open Access

    Metabolomic Network Analysis Reveals Reorganization of Lipid and Steroid Programs Linked to Right Ventricular-Pulmonary Vascular Function in Pulmonary Hypertension

    by Ivor Clinton, Julie Coursen, Darin Rosen, Karthik Suresh, Aparna Balasubramanian, Todd Matthew Kolb, Rachel L Damico, Stephen C Mathai, Steven Hsu, Monica Mukherjee, et al.

    Background: Pulmonary arterial hypertension (PAH) is characterized by circulating metabolic alterations, but whether these reflect disease-specific metabolic programs or reorganization of normal metabolic architecture, and how they relate to right ventricular-pulmonary vascular function (RV-PV), remains unclear. We hypothesized that the PAH metabolome is organized into biologically coherent, co-regulated metabolic modules whose relationships to RV-PV function would provide insight into known and novel metabolic pathways. Methods: We applied weighted gene correlation network analysis (WGCNA) to untargeted metabolomic data from 412 PAH patients enrolled in the multicenter PVDOMICS study. Module preservation analysis was performed in 85 healthy controls, with external replication in an independent single-center pulmonary hypertension cohort of 89 patients. Results: WGCNA identified 16 distinct metabolic modules organized around biologically coherent programs. A coherent fatty acid axis, spanning substrate pools, β-oxidation intermediates, and conjugated fatty acid disposal products, formed a central organizing structure, with downstream fatty acid oxidation modules strongly associated with adverse hemodynamics and worse RV-pulmonary artery (PA) coupling. Acylcholine-enriched and 5α-reduced androgen metabolite modules were associated with favorable hemodynamic indices. Module architecture was largely preserved in healthy controls, with subtle disease-associated modular reorganization, rather than emergence of novel modules, observed in PAH. Core modules were recovered in the replication cohort with conserved hub metabolites. Conclusions: These findings establish a systems-level framework demonstrating that PAH involves structured intensification and reorganization of interconnected metabolic programs associated with favorable and adverse RV-PV phenotypes. This work provides new insight into the metabolic architecture underlying PAH and identifies coordinated metabolic pathways linked to pulmonary vascular and right ventricular function.

  • Multi-beat pressure–volume loop-derived right ventricular–pulmonary arterial coupling predicts transplant-free survival in pulmonary arterial hypertension

    by Darin T. Rosen, Catherine E. Simpson, Rachel Damico, Aparna Balasubramanian, Matthew Kauffman, Todd M. Kolb, Stephen C. Mathai, Ryan J. Tedford, Stefan L. Zimmerman, Steven Hsu, et al.


  • Effects of Implementing a Standardized Risk Stratification and Triage Workflow for an Established Pulmonary Embolism Response Team

    by Hussein J. Hassan, Ryan G. Belecanech, Peter J. Leary, Gray R. Lyons, Clifford R. Weiss, Jennifer C. Yui, Hamza Aziz, Bo S. Kim, David N. Hager, Todd M. Kolb

    Rationale: The pulmonary embolism response team (PERT) model was developed to facilitate multispecialty decision-making and expedite therapeutic interventions for patients with pulmonary embolism (PE). PERT implementation has previously been associated with survival benefit in some studies, although specific workflow components that confer survival benefit have not been identified. Objectives: To measure the effects of PERT workflow revisions based upon risk stratification on clinical outcomes in an existing PERT. Methods: As a quality improvement initiative, we implemented three specific workflow interventions to an existing PERT program at an academic medical center: 1) designating triage responsibility to a specific group of providers; 2) assigning guideline-based risk stratification to all calls at triage; and 3) establishing intensive care unit admission guidelines on the basis of risk stratification. We used electronic medical records to review clinical outcomes for all PERT calls for 2 years after implementing the revised workflow and compared these with outcomes for the preceding 2-year period. We used logistic regression to compare the odds of in-hospital mortality before and after the workflow revision, with multiple models adjusted for clinically relevant variables. Results: During the study period (2019–2023), there were 420 unique patient PERT activations with confirmed PE; 253 patients were managed using the revised workflow, and 167 patients were managed using the historical workflow. The proportion of patients meeting the primary endpoint of in-hospital death at 30 days after the workflow revisions was significantly lower than during the historical period (6.3% vs. 18.0%; P < 0.001). Logistic regression analysis demonstrated the revised-PERT workflow to have a protective effect against in-hospital mortality (odds ratio = 0.31; 95% confidence interval = 0.16–0.59; P < 0.001). This mortality benefit remained significant after adjustment for demographics, clinical factors, hemodynamic instability, Pulmonary Embolism Severity Index class, and stage in the Bova scoring system. The workflow revisions were also associated with increased use of advanced therapies but did not change the proportion of patients with major bleeding or length of stay in the intensive care unit or hospital. Conclusions: In an existing PERT program, implementation of three specific workflow revisions centered around risk stratification and level-of-care triage improved survival for patients with PE. These findings suggest that incorporation of a standardized approach and risk stratification are valuable components of the PERT response.


  • Open Access

    Abn-BLIP: Abnormality-aligned Bootstrapping Language-Image Pre-training for pulmonary embolism diagnosis and report generation from CTPA

    by Zhusi Zhong, Yuli Wang, Lulu Bi, Zhuoqi Ma, Sun Ho Ahn, Christopher J. Mullin, Colin F. Greineder, Michael K. Atalay, Scott Collins, Grayson L. Baird, et al.


  • Lung Single-Cell Transcriptomics Reveal Diverging Pathobiology and Opportunities for Precision Targeting in Scleroderma-Associated Versus Idiopathic Pulmonary Arterial Hypertension

    by Tijana Tuhy, Julie C. Coursen, Tammy Graves, Michael Patatanian, Christopher Cherry, Shannon E. Niedermeyer, Sarah L. Khan, Darin T. Rosen, Michael P. Croglio, Mohab Elnashar, et al.

    BACKGROUND: Pulmonary arterial hypertension (PAH) involves progressive cellular and molecular change within the pulmonary vasculature, leading to increased vascular resistance. Current therapies targeting nitric oxide, endothelin, and prostacyclin pathways yield variable treatment responses. Patients with systemic sclerosis-associated PAH (SSc-PAH) often experience worse outcomes than those with idiopathic PAH (IPAH). We hypothesized that distinct and overlapping gene expression patterns in SSc-PAH versus IPAH lung tissues could inform the investigation of precision-targeted therapies. METHODS: Lung tissue samples from 4 SSc-PAH, 4 IPAH, and 4 failed donor specimens were obtained from the Pulmonary Hypertension Breakthrough Initiative lung tissue bank. Single-cell RNA sequencing was performed using the 10X Genomics Chromium Flex platform. Data normalization, clustering, and differential expression analysis were conducted using Seurat. Additional analyses included gene set enrichment analysis, transcription factor activity analysis, and ligand-receptor signaling. Pharmacotranscriptomic screening was performed using the Connectivity Map. RESULTS: SSc-PAH samples showed a higher proportion of fibroblasts compared with failed donors and a higher proportion of dendritic cells/macrophages compared with IPAH. Gene set enrichment analysis revealed enriched pathways related to epithelial-to-mesenchymal transition, apoptosis, and vascular remodeling in SSc-PAH samples. There was pronounced differential gene expression across diverse pulmonary vascular cell types and in various epithelial cell types in both IPAH and SSc-PAH, with epithelial-to-endothelial cell signaling observed. Macrophage-to-endothelial cell signaling was particularly pronounced in SSc-PAH. Pharmacotranscriptomic screening identified TIE2, GSK-3, and PKC inhibitors, among other compounds, as potential drug candidates for reversing SSc-PAH gene expression signatures. CONCLUSIONS: Overlapping and distinct gene expression patterns exist in SSc-PAH versus IPAH, with significant molecular differences suggesting unique pathogenic mechanisms in SSc-PAH. These findings highlight the potential for precision-targeted therapies to improve outcomes in patient with SSc-PAH. Future studies should validate these targets and explore their therapeutic efficacy.


  • Open Access

    Dysregulated Tricarboxylic Acid Cycle Metabolism Is Associated With Right Ventricular Maladaptation in Pulmonary Vascular Disease

    by Darin T Rosen, Todd M Kolb, Stephen C Mathai, Karthik Suresh, Rachel Damico, Steven Hsu, Ryan J Tedford, Anna R Hemnes, Jane A Leopold, Evelyn M Horn, et al.

    Background: Right ventricular (RV) maladaptation to elevated pulmonary afterload is the primary determinant of outcomes in pulmonary artery (PA) hypertension; however, the pathobiological mechanisms underlying RV decompensation remain poorly understood. Methods: We performed global untargeted metabolomics on plasma from 55 patients who underwent gold‐standard RV‐PA coupling measurements using multibeat pressure volume loop assessment in a single‐center cohort and from 1027 patients with coupling surrogate measurements in a larger multicenter cohort, the PVDOMICS (Pulmonary Vascular Disease Phenomics) study. Age and sex‐adjusted linear regression was performed to identify associations between metabolites and coupling metrics. Additionally, we performed a metabolic flux analysis using gene expression data from RV tissue in an independent cohort of 32 patients. Partial least squares–discriminant analysis was used to identify metabolites and reactions characteristic of the decompensated RV. Results: RV‐PA coupling was negatively associated with tricarboxylic acid (TCA) cycle intermediate levels. Specifically, plasma α‐ketoglutarate and fumarate were significantly associated with all coupling metrics in both cohorts. Metabolic flux analysis indicated that decompensated RVs exhibited aberrant TCA cycle activity, including reduced acetyl coenzyme A entry and increased lactate elimination, suggesting a shift from the TCA cycle toward glycolysis at the RV tissue level. Conclusions: We identify an association between circulating TCA cycle intermediate levels and RV‐PA uncoupling in 2 independent cohorts, and dysregulated TCA cycle metabolism in decompensated PA hypertension RVs, suggesting that aberrant TCA cycle metabolism could represent a hallmark of RV maladaptation in PA hypertension. Further study of this pathway is warranted to develop novel biomarkers of RV function or RV‐targeted therapies.


  • Open Access

    Physiological shear stress suppresses apoptosis in human pulmonary microvascular endothelial cells

    by Simin Yan, Nicolas M. Philip, Samuel T. Murray, Xin Yun, Michael P. Croglio, Karthik Suresh, Mahendra Damarla, Larissa A. Shimoda, Todd M. Kolb

    Physiological shear stress contributes to maintaining endothelial cell homeostasis, including suppression of apoptosis. In the pulmonary circulation, diseases such as pulmonary embolism and pulmonary hypertension result in alterations in shear stress. Shear stress has been reported to suppress endothelial apoptosis through phosphatidylinositol 3‐kinase (PI3K) activation, but evidence from human pulmonary microvascular endothelial cells (PMVECs) is lacking. We hypothesized that physiological shear stress activates PI3K to reduce apoptosis in human PMVECs. We utilized the orbital shaker model of shear stress to test our hypothesis. Apoptosis was evaluated by measuring chromatin condensation, caspase 3/7 activity, and DNA fragmentation. We found that shear stress caused a rapid and sustained increase in protein kinase B (Akt) phosphorylation, a surrogate for activated PI3K, in human PMVECs. Under static conditions, PI3K inhibition with LY294002 or challenge with the kinase inhibitor staurosporine (STS) induced apoptosis in PMVECs. Following exposure to shear stress for 24 h, LY294002‐ and STS‐induced apoptosis was reduced. The anti‐apoptotic effect of shear stress in STS‐challenged cells was reversed by PI3K inhibition. We conclude that physiological shear stress increases PI3K/Akt activity and suppresses apoptosis in normal human PMVECs.


  • Open Access

    Studying the Pulmonary Endothelium in Health and Disease: An Official American Thoracic Society Workshop Report

    by Rebecca F. Hough, Cristina M. Alvira, Julie A. Bastarache, Serpil C. Erzurum, Wolfgang M. Kuebler, Eric P. Schmidt, Larissa A. Shimoda, Steven H. Abman, Diego F. Alvarez, Patrick Belvitch, et al.

    Lung endothelium resides at the interface between the circulation and the underlying tissue, where it senses biochemical and mechanical properties of both the blood as it flows through the vascular circuit and the vessel wall. The endothelium performs the bidirectional signaling between the blood and tissue compartments that is necessary to maintain homeostasis while physically separating both, facilitating a tightly regulated exchange of water, solutes, cells, and signals. Disruption in endothelial function contributes to vascular disease, which can manifest in discrete vascular locations along the artery-to-capillary-to-vein axis. Although our understanding of mechanisms that contribute to endothelial cell injury and repair in acute and chronic vascular disease have advanced, pathophysiological mechanisms that underlie site-specific vascular disease remain incompletely understood. In an effort to improve the translatability of mechanistic studies of the endothelium, the American Thoracic Society convened a workshop to optimize rigor, reproducibility, and translation of discovery to advance our understanding of endothelial cell function in health and disease.